Thrombocytopenia and craniotomy for tumor: A National Surgical Quality Improvement Program analysis

Cancer

Volumn 122, Issue 11, 2016, Pages 1708-1717

  Dasenbrock, Hormuzdiyar H ^a   Devine, Christopher A ^a   Liu, Kevin X ^a   Gormley, William B ^a   Claus, Elizabeth B ^a   Smith, Timothy R ^a   Dunn, Ian F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

brain tumor; craniotomy; National Surgical Quality Improvement Program (NSQIP); outcomes; platelet; thrombocytopenia

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BRAIN TUMOR; CANCER SURGERY; CONTROLLED STUDY; CRANIOTOMY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REOPERATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; BLOOD; BRAIN NEOPLASMS; CLASSIFICATION; COMPLICATION; CONFIDENCE INTERVAL; FACTUAL DATABASE; INTRACRANIAL HEMORRHAGES; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; PROGRAM EVALUATION; PROPORTIONAL HAZARDS MODEL; REGISTER; STANDARDS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; BRAIN NEOPLASMS; CONFIDENCE INTERVALS; CRANIOTOMY; DATABASES, FACTUAL; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; LOGISTIC MODELS; MALE; MIDDLE AGED; PLATELET COUNT; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; PROGRAM EVALUATION; PROPORTIONAL HAZARDS MODELS; QUALITY IMPROVEMENT; REGISTRIES; REOPERATION; THROMBOCYTOPENIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84962525995     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29984     Document Type: Article

References (14)

1. Chan KH, Mann KS, Chan TK,. The significance of thrombocytopenia in the development of postoperative intracranial hematoma. J Neurosurg. 1989; 71: 38-41.
2. Dutcher JP, Schiffer CA, Aisner J, et al., Incidence of thrombocytopenia and serious hemorrhage among patients with solid tumors. Cancer. 1984; 53: 557-562.
3. Kaufman RM, Djulbegovic B, Gernsheimer T, et al,; AABB. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015; 162: 205-213.
4. Hogshire LC, Patel MS, Rivera E, Carson JL,. Evidence review: periprocedural use of blood products. J Hosp Med. 2013; 8: 647-652.
5. Anglin CO, Spence JS, Warner MA, et al., Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses. J Neurosurg. 2013; 118: 676-686.
6. Seicean A, Seicean S, Schiltz NK, et al., Short-term outcomes of craniotomy for malignant brain tumors in the elderly. Cancer. 2013; 119: 1058-1064.
7. Kleinbaum DG, Klein M,. Survival Analysis: A Self-Learning Text. 3rd ed. Medford, MA: Springer; 2012.
8. Hosmer DW, Lemeshow S, Sturdivant RX,. Applied Logistic Regression. Malden, MA: John Wiley & Sons; 2013.
9. Engstrom M, Romner B, Schalen W, Reinstrup P,. Thrombocytopenia predicts progressive hemorrhage after head trauma. J Neurotrauma. 2005; 22: 291-296.
10. Stansbury LG, Hess AS, Thompson K, Kramer B, Scalea TM, Hess JR,. The clinical significance of platelet counts in the first 24 hours after severe injury. Transfusion. 2013; 53: 783-789.
11. Schnuriger B, Inaba K, Abdelsayed GA, et al., The impact of platelets on the progression of traumatic intracranial hemorrhage. J Trauma. 2010; 68: 881-885.
12. Joseph B, Aziz H, Zangbar B, et al., Acquired coagulopathy of traumatic brain injury defined by routine laboratory tests: which laboratory values matter? J Trauma Acute Care Surg. 2014; 76: 121-125.
13. Joseph B, Pandit V, Meyer D, et al., The significance of platelet count in traumatic brain injury patients on antiplatelet therapy. J Trauma Acute Care Surg. 2014; 77: 417-421.
14. Washington CW, Derdeyn CP, Dacey RG Jr, Dhar R, Zipfel GJ,. Analysis of subarachnoid hemorrhage using the Nationwide Inpatient Sample: the NIS-SAH Severity Score and Outcome Measure. J Neurosurg. 2014; 121: 482-489.